Logo do repositório
Tudo no RIUFPA
Documentos
Contato
Sobre
Ajuda
  • Português do Brasil
  • English
  • Español
  • Français
Entrar
Novo usuário? Clique aqui para cadastrar. Esqueceu sua senha?
  1. Início
  2. Pesquisar por Assunto

Navegando por Assunto "Hemoterapia"

Filtrar resultados informando as primeiras letras
Agora exibindo 1 - 1 de 1
  • Resultados por página
  • Opções de Ordenação
  • Carregando...
    Imagem de Miniatura
    ItemAcesso aberto (Open Access)
    Soroconversões para o vírus da Hepatite C entre doadores de sangue de repetição da Fundação Hemopa: análise do uso do NAT como elemento da segurança transfusional
    (Universidade Federal do Pará, 2014) VALOIS, Rubenilson Caldas; QUARESMA, Juarez Antônio Simões; http://lattes.cnpq.br/3350166863853054
    The Hepatitis C virus is currently one of the main causes of hepatic cirrhosis and hepatocellular carcinoma; it also constitutes one of the main reasons of unsuitability for blood donation among the population. Hepatitis C presents itself as one of the main infectious diseases in the worldwide scenario. The aim of this work was to conduct a comparative study and a analysis of the methods of screening for HCV in blood donors of the Foundation Center of Hematology and Hemotherapy of Pará (HEMOPA) before and after the implementation of NAT test. The methodology used had a quantitative, prospective, with general objectives of descriptive nature approach, and used a technical procedure with pre-existent written registrations in HEMOPA Foundation. There were 125 seroconversions to HCV diagnosed by ELISA, and 176 diagnosed by NAT, associated with chemiluminescence, totalizing 301 seroconversions from April 2013 to September 2014. It was observed in the study that there was a higher rate of seroconversions when the technique of molecular biology was used, which is associated with an immunological test, instead of the ELISA methodology. In the study most people were male, under 35 years old, unmarried, and had complete high school level. It was observed that among the risk factors studied, the “Surgery” one was statistically significant. We concluded that there is an important clue that the combined use of molecular and immunological tests improves security in the process of blood donors selection.
Logo do RepositórioLogo do Repositório
Nossas Redes:

DSpace software copyright © 2002-2025 LYRASIS

  • Configurações de Cookies
  • Política de Privacidade
  • Termos de Uso
  • Entre em Contato
Brasão UFPA